Streamex Corp.
Organization details
- Legal name
- Streamex Corp.
- Former names
- BioSig Technologies, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Winter Park
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- STEX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001530766
- EIN
- 26-4333375
Board of directors
-
Anthony Mark Marciano · DirectorSince 2026
-
Anthony N. Amato · Director · Chief Executive OfficerSince 2024
-
Christopher Allen Baer · DirectorSince 2024
-
Donald Browne · DirectorSince 2024
-
Donald E. Foley · DirectorSince 2023
-
Frederick Hrkac · DirectorSince 2023
-
Iv David Weild · DirectorSince 2023
-
James J. Barry · DirectorSince 2023
-
James L. Klein · DirectorSince 2023
-
Karl Henry Michael McPhie · Director · CEOSince 2025
-
Kenneth L. Londoner · Director · Chief Executive OfficerSince 2023
-
Kevin Roy Gopaul · DirectorSince 2025
-
Mitchell Young Williams · Director · Chief Investment OfficerSince 2026
-
Morgan Lee Lekstrom · Director · Interim Executive ChairmanSince 2025
-
Patrick Joseph Gallagher · DirectorSince 2023
- Since 2026
-
Steven Eric Abelman · DirectorSince 2024
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
122.2% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2024.
Director election results
Annual meeting of December 30, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.6%
-
99.9%
Board connections
3 of this board's directors also sit on 7 other boards.
- via Shawn Matthews
- via Patrick Joseph Gallagher
- via Shawn Matthews
- via Shawn Matthews
- via Iv David Weild
- via Shawn Matthews
- via Shawn Matthews
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,123,569
- 17 purchases by 4 insiders
- Sold, last 12 months
- $346,996
- 7 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Mitchell Young Williams Director, Officer (Chief Investment Officer) | Open-market sale | −72,689 | $0.72 | $52,336 |
| Aug 1, 2026 | Mitchell Young Williams Director, Officer (Chief Investment Officer) | Shares withheld for tax | −55,335 | $0.71 | $39,282 |
| Jul 1, 2026 | Kevin Roy Gopaul Director | Grant or award | +100,000 | — | — |
| Jul 1, 2026 | Shawn Matthews Director | Grant or award | +100,000 | — | — |
| Jun 12, 2026 | Morgan Lee Lekstrom Director, Officer (Interim Executive Chairman) | Open-market purchase | +25,000 | $1.01 | $25,250 |
| Jun 12, 2026 | Morgan Lee Lekstrom Director, Officer (Interim Executive Chairman) | Open-market purchase | +25,000 | $0.98 | $24,500 |
| Jun 1, 2026 | Mitchell Young Williams Director, Officer (Chief Investment Officer) | Open-market sale | −23,810 | $1.05 | $25,001 |
| May 28, 2026 | Morgan Lee Lekstrom Director, Officer (Interim Executive Chairman) | Open-market purchase | +34,000 | $1.47 | $49,980 |
| May 21, 2026 | Anthony Mark Marciano Director | Open-market purchase | +17,745 | $1.13 | $20,052 |
| May 21, 2026 | Morgan Lee Lekstrom Director, Officer (Interim Executive Chairman) | Open-market purchase | +41,048 | $1.02 | $41,869 |
| May 21, 2026 | Morgan Lee Lekstrom Director, Officer (Interim Executive Chairman) | Open-market purchase | +53,952 | $1.04 | $56,110 |
| May 21, 2026 | Morgan Lee Lekstrom Director, Officer (Interim Executive Chairman) | Open-market purchase | +52,000 | $1.06 | $55,120 |
| May 1, 2026 | Mitchell Young Williams Director, Officer (Chief Investment Officer) | Open-market sale | −263,863 | $0.79 | $208,452 |
| Apr 28, 2026 | Mitchell Young Williams Director, Officer (Chief Investment Officer) | Grant or award | +2,250,000 | — | — |
| Apr 15, 2026 | Plummer Christine Marie Officer (Chief Financial Officer) | Open-market sale | −2,581 | $1.08 | $2,787 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.